超声乳化人工晶体植入治疗轴性近视合并白内障的临床观察

Clinical efficacy of phacoemlsification and intraocular lens implantation in the treatment of axial myopia combined with cataract

目的观察采用白内障超声乳化联合人工晶体植入术治疗超高度轴性近视合并白内障患者的临床疗效。方法对63例(95眼)超高度轴性近视合并白内障患者行超声乳化人工晶体植入术,术后随访3个月,记录视力及并发症情况。结果手术后3个月最佳矫正视力大于或等于0.6占49%,最佳矫正视力大于或等于0.3占79%。最佳矫正视力小于0.3占21%,最佳矫正视力小于0.05占7%。术前与术后最佳矫正视力比较,差异有统计学意义(t=11.238,P<0.05)。结论白内障超声乳化联合人工晶体植入术治疗超高度轴性近视合并白内障是安全有效的。

Objective To evaluate the therapeutic effect of phacoemlsification and intraocular lens implantation in the treatment of axial myopia combined with cataract .Methods Phacoemlsification and intraocular lens implanta-tion was performed in 95 eyes of 63 patients .The postoperative effects were observed .Results The proportion of pa-tients with postoperative corrected vision of at least 0 .6 ,at least 0 .3 ,less than 0 .3 and less than 0 .05 were 49% , 79% ,21% and 7% .Corrected visions detected before and after operation were with statistical difference （t=11 .238 , P〈0 .05） .Conclusion Combination of phacoemlsification and intraocular lens implantation might be safe and effec-tive for the therapy of axial myopia combined with cataract .